Let’s start up with the current stock price of Abeona Therapeutics Inc. (ABEO), which is $3.39 to be very precise. The Stock rose vividly during the last session to $3.50 after opening rate of $2.67 while the lowest price it went was recorded $2.62 before closing at $2.58.
Recently in News on February 2, 2021, Abeona Therapeutics Announces Clinical Investigator Webinar to Review ABO-102 and ABO-101 Clinical Data Presented at the 17th Annual WORLDSymposium™. Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that it will host a live webinar for the investment community on Tuesday, February 16, 2021 at 1:00 p.m. EST to review clinical data on the company’s investigational AAV-based gene therapies ABO-102 and ABO-101 presented at the 17th Annual WORLDSymposium™. You can read further details here
Abeona Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.50 on 02/08/21, with the lowest value was $1.50 for the same time period, recorded on 01/04/21.
Abeona Therapeutics Inc. (ABEO) full year performance was 35.06%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Abeona Therapeutics Inc. shares are logging -21.89% during the 52-week period from high price, and 242.60% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.99 and $4.34.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 16453708 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Abeona Therapeutics Inc. (ABEO) recorded performance in the market was 115.92%, having the revenues showcasing 225.96% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 318.49M, as it employees total of 88 workers.
Analysts verdict on Abeona Therapeutics Inc. (ABEO)
During the last month, 0 analysts gave the Abeona Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.57, with a change in the price was noted +1.38. In a similar fashion, Abeona Therapeutics Inc. posted a movement of +68.66% for the period of last 100 days, recording 2,750,809 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ABEO is recording 0.02 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Abeona Therapeutics Inc. (ABEO): Technical Analysis
Raw Stochastic average of Abeona Therapeutics Inc. in the period of last 50 days is set at 94.81%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 93.99%. In the last 20 days, the company’s Stochastic %K was 94.24% and its Stochastic %D was recorded 88.20%.
Let’s take a glance in the erstwhile performances of Abeona Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 115.92%. Additionally, trading for the stock in the period of the last six months notably improved by 18.53%, alongside a boost of 35.06% for the period of the last 12 months. The shares increased approximately by 74.74% in the 7-day charts and went down by 90.45% in the period of the last 30 days. Common stock shares were driven by 225.96% during last recorded quarter.